BuildingResistanceto AMR▶AMR AllianceJapanis Working toCombatAntimicrobialResistanceAnti mi crobial Resis ta nce (AMR) refers to the phenomena by whi ch ba cteria become i mmune to a nti mi crobial trea tments over time as thosetrea tments a re used more and more. Infecti ous diseases caused by a ntimi crobial resis tant ba cteria can be diffi cul t to trea t, or even fa tal in wors tcase scenari os. As a mul ti-stakeholder alliance of government, a cademia, ci vil society, a nd pri va te sector members , AMR Alliance Japan works
wi th i ts domestic and foreign partners to promote policies that strengthen AMR countermeasures.

As ma ny as
700,000 people
worl dwide die from
AMR-rel ated causes
every yea r

By 2050, AMR-related
morta lity i s
expected to riseto 10 mi l lion
people annually

Al ready in Japan,i t i s estimatedtha t 8,000 people
di e of AMR-related
ca uses every year

By 2050, i t i s
projected that AMR
rel a ted costs willri s e to $100 tri llion peryea r worl dwide▶AboutAMRAllianceJapan
Es ta blished i n November 2018 by a ca demic societiesworking i n i nfectious disease medicine, pharmaceutical companies, and medical device
ma kers, AMR Al liance Japan is an independent platform for the promotion of multisector discussion on AMR countermeasures. AMR Al lianceJa pan works to 1) realize AMR countermeasures i n l ine wi th the current s ituation faced by medical practitioners a nd patients; 2) promote theAMR pol icy a genda domestically and abroad; a nd 3) create and promote policy recommendations on the actions expected of Japan on AMR.

▶CurrentMembers(inalphabeticalorder, as of December,2023):
bi oMéri eux Ja pan Ltd., Gl axoSmithKline K.K., Hi meji Ci ty, Ja pan Medical Association, Japan Pha rmaceutical
As s ociation, Ja pan Pharmaceutical Ma nufacturers As sociation, Ja panese Association of Medical Technologists,
Ja pa nese Soci ety for Pediatri c Infectious Diseases, Ja panese Society of Anti mi crobials for Ani mals, JapaneseSoci ety of Chemotherapy, Ja panese Society of Hospital Pharmacists, “Kodomo to l ryo” Project, Mei ji Seika
Pha rma Co., Ltd., MSD K.K., Ni ppon Becton, Dickinson a nd Company, Ltd., Pfi zer Ja pan Inc., Shimadzu Diagnostics
Corpora ti on, Shionogi & Co., Ltd., Sumi tomo-Pharma Co., Ltd., The Ja panese Society for Medi cal Mycol ogy, The
Ja pa nese Associati on for Infectious Diseases, The Ja panese Society for Cl i nical Mi crobiology, The Japanese Society
for Infection Prevention and Control, The Ja panese Society of Pha rmaceutical Health Ca re and Sci ences, TheJa pa nese Soci ety of Therapeutic Drug Monitoring, The Pharmaceutical Society of Ja pan, Health and Global Pol icy
Ins titute (HGPI) serves as Secretariat of the Alliance.

▶AbouttheAlliance’sPolicyRecommendations
On Jul y 11, 2019, AMR Al l iance Japan a nnounced “AMR Alliance Japan Policy Recommendations: The Japanese Government’s Role in Promoting
AMR Countermeasures.” The themes of the policy recommendations are as follows.
• Promoti ng antimicrobial s tewardship based on the actual situation at healthcare facilities• Cons tructing domestic AMR s urveillance a nd crisis management s ystems• Ena bling the further and active use of AMR s creening methods and ra pid diagnostic technology• Supporting education on AMR for the public a nd medical practitioners• Es tablishing incentive models to encourage R&D for antimicrobials• Stabilizing the s upply of a ntimicrobials• International collaborations to share case s tudies and l essons l earned on AMR domestically a nd abroad▶RecentActivities
November 08, 2018
July 11, 2019

October 3, 2019
November 20, 2020

Global Expert Meeting to Commemorate the Establishment of AMR Alliance Japan
Recommendations - The Japanese Government’s Role in Promoting AMR Countermeasures (AMR Alliance Japan)

AMR Alliance Japan Delivered Policy Recommendations on AMR to Minister of Health, Labour and Welfare, Katsunobu Kato
New Policy Briefs on the Situation of AMR in Japan and Abroad

March 24,2021

Recommendations - Creating Pull Incentives for Antimicrobials (Secretariat: AMR Alliance Japan. Part of the Nikkei FT Communicable Diseases
Conference Asia Africa Medical Innovation Consortium)

May 30, 2022

Urgent Recommendation - the Basic Policy on Economic and Fiscal Management and Reform 2022

August 18, 2022

HGPI Special Seminar “Universal Health Coverage in an Era of Antimicrobial Resistance”

November 10, 2022

AMR Alliance Japan Delivered Policy Recommendations on AMR to Minister of Health, Labour and Welfare, Katsunobu Kato and Minister ofForeign Affairs, Yoshimasa Hayashi

December 19, 2022

Recommendations - The Political Leadership and International Collaboration Needed to Advance Antimicrobial Resistance (AMR)
Countermeasures

February 28, 2023

AMR Special Symposium “Reframing AMR as the Infrastructure Guarding the World: Building Multi-Stakeholder Commitment to the One HealthApproach Looking to the G7, UNGA, and Beyond”

April 28, 2023

Recommendations to Prime Minister Fumio Kishida on the issue of antimicrobial resistance (AMR) in the G7 Hiroshima Summit Leaders'
Declaration

AMR Alliance JapanWebsite

Secretariat: Health and Global Policy Institute
Grand Cube 3F, Otemachi Financial City, Global Business Hub
Tokyo1-9-2, Otemachi, Chiyoda-ku, Tokyo 100-0004 JAPANTEL: +81-3-4243-7156 FAX: +81-3-4243-7378
Mail: info@hgpi.org Website: https://www.hgpi.org/en/